blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1954258

EP1954258 - MATERIALS AND METHODS FOR TREATING INFLUENZA VIRAL INFECTIONS WITH A CYSTEAMINE COMPOUND [Right-click to bookmark this link]
Former [2008/33]MATERIALS AND METHODS FOR TREATING VIRAL INFECTIONS WITH A CYSTEAMINE COMPOUND
[2012/11]
StatusNo opposition filed within time limit
Status updated on  12.07.2013
Database last updated on 16.11.2024
Most recent event   Tooltip30.05.2014Lapse of the patent in a contracting state
New state(s): LU
published on 02.07.2014  [2014/27]
Applicant(s)For all designated states
OBIO Pharmaceutical (H.K.) Limited
Suite 1211, 12/F., Tower 2, Silvercord
30 Canton Road, Tsimshatsui
Kowloon, Hong Kong / HK
[2012/38]
Former [2008/33]For all designated states
OMEGA-BIOPHARMA (H.K.) LIMITED
Unit 613, 6/F West Wing Office Building New World Center 20 Salisbury Road
Tsimshatsui, Kowloon, Hong Kong / CN
Inventor(s)01 / LIANG, Hao, Yi
R. 801 NO. 1 2nd Street
Zijing Garden, East Linhe Road
Tianhe, Guangzhou, 510610 / CN
02 / CHI, Francis
Flat D, 11/F Tower 10
Beverly Villas, 16 La Salle Road
Kowloon, Hong Kong / CN
03 / XU, Qingfu
1571 Elmwood Ave, Apt 4
Rochester, NY 14620 / US
04 / CHAN, Bill, Piu
6-2-8A, Citichamp Palace
Madian Haldian Distric
Beijing, 100088 / US
 [2012/36]
Former [2008/33]01 / LIANG, Hao, Yi
R. 801 NO. 1 2nd Street Zijing Garden, East Linhe Road
Tianhe, Guangzhou, 510610 / CN
02 / CHI, Francis
Flat D, 11/F Tower 10 Beverly Villas, 16 La Salle Road
Kowloon, Hong Kong / CN
03 / XU, Qingfu
1571 Elmwood Ave, Apt 4
Rochester, NY 14620 / US
04 / CHAN, Bill, Piu
6-2-8A, Citichamp Palace Madian Haldian Distric
Beijing, 100088 / US
Representative(s)Clarke, Lionel Paul
Gill Jennings & Every LLP The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[N/P]
Former [2012/36]Clarke, Lionel Paul
Gill Jennings & Every LLP The Broadgate Tower 20 Primrose Street
London EC2A 2ES / GB
Former [2008/33]Clarke, Lionel Paul
Gill Jennings & Every LLP Broadgate House 7 Eldon Street
London EC2M 7LH / GB
Application number, filing date06838553.328.11.2006
[2008/33]
WO2006US45652
Priority number, dateUS20050740584P28.11.2005         Original published format: US 740584 P
US20060810773P02.06.2006         Original published format: US 810773 P
US20060818885P06.07.2006         Original published format: US 818885 P
US20060847020P25.09.2006         Original published format: US 847020 P
[2008/33]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007062272
Date:31.05.2007
Language:EN
[2007/22]
Type: A1 Application with search report 
No.:EP1954258
Date:13.08.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 31.05.2007 takes the place of the publication of the European patent application.
[2008/33]
Type: B1 Patent specification 
No.:EP1954258
Date:05.09.2012
Language:EN
[2012/36]
Type: B8 Corrected title page of specification 
No.:EP1954258
Date:10.10.2012
[2012/41]
Search report(s)International search report - published on:EP31.05.2007
ClassificationIPC:A61K31/145, A61P31/12, A61P31/16
[2008/33]
CPC:
A61K31/145 (EP,KR,US); A61K31/13 (EP,KR,US); A61K45/06 (EP,US);
A61P31/12 (EP); A61P31/16 (EP); A61P43/00 (EP);
Y02A50/30 (EP,US) (-)
C-Set:
A61K31/145, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/33]
TitleGerman:MATERIAL UND VERFAHREN ZUR BEHANDLUNG VON INFLUENZA VIRUSINFEKTIONEN MIT EINER CYSTEAMIN-VERBINDUNG[2012/11]
English:MATERIALS AND METHODS FOR TREATING INFLUENZA VIRAL INFECTIONS WITH A CYSTEAMINE COMPOUND[2012/11]
French:SUBSTANCES ET METHODES DE TRAITEMENT D'INFECTIONS VIRALES D' INFLUENZA PAR UN COMPOSE DE CYSTEAMINE[2012/11]
Former [2008/33]MATERIAL UND VERFAHREN ZUR BEHANDLUNG VON VIRUSINFEKTIONEN MIT EINER CYSTEAMIN-VERBINDUNG
Former [2008/33]MATERIALS AND METHODS FOR TREATING VIRAL INFECTIONS WITH A CYSTEAMINE COMPOUND
Former [2008/33]SUBSTANCES ET METHODES DE TRAITEMENT D'INFECTIONS VIRALES PAR UN COMPOSE DE CYSTEAMINE
Entry into regional phase31.03.2008National basic fee paid 
31.03.2008Designation fee(s) paid 
31.03.2008Examination fee paid 
Examination procedure31.03.2008Amendment by applicant (claims and/or description)
31.03.2008Examination requested  [2008/33]
08.05.2009Despatch of a communication from the examining division (Time limit: M04)
24.08.2009Reply to a communication from the examining division
20.09.2010Despatch of a communication from the examining division (Time limit: M02)
18.11.2010Reply to a communication from the examining division
08.03.2012Communication of intention to grant the patent
02.07.2012Fee for grant paid
02.07.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  08.05.2009
Opposition(s)06.06.2013No opposition filed within time limit [2013/33]
Fees paidRenewal fee
12.11.2008Renewal fee patent year 03
12.11.2009Renewal fee patent year 04
24.11.2010Renewal fee patent year 05
23.11.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY05.09.2012
EE05.09.2012
LT05.09.2012
LV05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
LU28.11.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
[2014/27]
Former [2014/21]CY05.09.2012
EE05.09.2012
LT05.09.2012
LV05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
Former [2013/34]CY05.09.2012
EE05.09.2012
LT05.09.2012
LV05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
Former [2013/23]CY05.09.2012
EE05.09.2012
LT05.09.2012
LV05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
GR06.12.2012
IS05.01.2013
Former [2013/22]CY05.09.2012
EE05.09.2012
LT05.09.2012
LV05.09.2012
SI05.09.2012
GR06.12.2012
IS05.01.2013
Former [2013/11]CY05.09.2012
LT05.09.2012
LV05.09.2012
SI05.09.2012
GR06.12.2012
Former [2013/10]CY05.09.2012
LT05.09.2012
Former [2013/08]LT05.09.2012
Cited inInternational search[X]US5554655  (THOENE JESS G [US]) [X] 1-36 * column 4, paragraph 4 - column 5 * * claims 1-18 *;
 [X]DE19817511  (SLENCZKA WERNER [DE]) [X] 1-36 * column 3, lines 15-63 *;
 [X]  - BERGAMINI A ET AL, "IN VITRO INHIBITION OF THE REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 BY BETA-MERCAPTOETHYLAMINE (CYSTEAMINE)", JOURNAL OF INFECTIOUS DISEASES, CHICAGO, IL, US, (1996), vol. 174, no. 1, ISSN 0022-1899, pages 214 - 218, XP009033797 [X] 1-36 * page 215, column L, paragraph 3 - column R, paragraph 4 *
 [X]  - ANDERSON ROBERT A JR ET AL, "Characterization of cysteamine as a potential contraceptive anti-HIV agent", JOURNAL OF ANDROLOGY, (199801), vol. 19, no. 1, ISSN 0196-3635, pages 37 - 49, XP009079779 [X] 1-36 * abstract *
 [X]  - THOENE J G, "IN VITRO EFFECTIVENESS OF AMINOTHIOLS AND DISULFIDES AGAINST HIV-I", CLINICAL RESEARCH, THOROFARE, NJ, US, (1992), vol. 40, no. 2, ISSN 0009-9279, page 246A, XP002079347 [X] 1-36 * abstract *
by applicantUS3152180
 US3352912
 US3483254
 US3496228
 US3534084
 US3538160
 US3592934
 US5554655
 US5684024
 US5714519
 US5821243
 US5935957
 US6271373
 US6468522
 US6521266
    - Fields Virology, (1990), vol. 1, pages 1075 - 1152
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.